Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy" reports on the integration of deep learning and generative AI in radiopharmaceutical medicine, its impact on ...

AI-enhanced analysis of conventional MRI scans reveals thousands of hidden cortical lesions in multiple sclerosis, potentially opening a new window into disease progression.

Researchers say ability to see for the first time previously hidden indicators of MS disease progression is an important advance.

Abstract: The "magnetic resonance imaging (MRI)" technique of detecting brain tumors is vital in clinical diagnosis and creating treatment strategies. This paper uses the Figshare Brain Tumor ...

Researchers from the Terasaki Institute for Biomedical Innovation, together with key pioneers in glioma biology, neuro-oncology and stem cell biology, have published a comprehensive review in Society ...

As the state investigates a possible cancer cluster at a high school, many Herald readers have asked whatever happened with the potential tumor cluster at a local hospital. Seven current and former ...

A brain tumor can strike anyone at any age, impacting a person’s very essence — everything from cognition and personality to movement and speech — if it’s fast-growing and aggressive. It can be the ...

Abstract: Brain tumors rank among the most lethal forms of cancer, and their early detection is crucial for improving patient outcomes. Beyond timely identification, accurately determining tumor type ...

A DEEP learning model for brain tumour detection demonstrates high diagnostic accuracy and reduced false positives, offering a scalable approach to improve magnetic resonance imaging interpretation in ...

Brain cancer is one of the deadliest diseases — and early detection is crucial for better outcomes. There are obvious symptoms like sudden, severe headaches and dizziness, while subtle signs such as ...

Biomarkers play a pivotal role in contemporary cancer immunotherapy by guiding diagnosis, patient stratification, therapeutic decision-making, and longitudinal assessment of treatment responses.